Trexquant Investment’s Olema Pharmaceuticals OLMA Stock Holding History

Trexquant Investment’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.85M	Buy	325,173 +275,419	+554%	+$6.13M	0.03%	660
2025 Q4	$1.24M	Buy	+49,754	New	+$885K	0.01%	1115
2024 Q4	–	Sell	-120,093	Closed	-$1.43M	–	1774
2024 Q3	$1.43M	Buy	120,093 +5,451	+5%	+$69.7K	0.02%	923
2024 Q2	$1.24M	Buy	+114,642	New	+$1.24M	0.02%	930
2023 Q4	–	Sell	-11,151	Closed	-$138K	–	1681
2023 Q3	$138K	Buy	+11,151	New	+$114K	﹤0.01%	1378
2021 Q3	–	Sell	-12,335	Closed	-$345K	–	1385
2021 Q2	$345K	Buy	+12,335	New	+$351K	0.03%	645

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Trexquant Investment's OLMA Position: Q1 2026 in Review

Trexquant Investment increased its Olema Pharmaceuticals (OLMA) stake by 554% in Q1 2026, buying an estimated $6.13M and bringing the position to 325,173 shares worth $4.85M. The position accounts for 0.03% of the portfolio, ranked #660.

Trexquant Investment first reported a position in OLMA in Q2 2021 and has held it in 6 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

Trexquant Investment held 325,173 shares of Olema Pharmaceuticals worth $4.85M as of Q1 2026.
Trexquant Investment bought 275,419 Olema Pharmaceuticals shares in Q1 2026, an estimated $6.13M.
Olema Pharmaceuticals made up 0.03% of Trexquant Investment's portfolio in Q1 2026, its #660 holding.
Trexquant Investment first reported a position in Olema Pharmaceuticals in Q2 2021 and has held it in 6 quarters since.
195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.